SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabets quarterly results triggered a sharp selloff as earnings and key advertising businesses missed expectations, while investors focused on heavy AI infrastructure spending and pressure on free cash flow. Traders are divided: bears see spending and profitability risks, while bulls point to strong Google Cloud growth and call the decline an overreaction.

Alphabet Inc - Ordinary Shares - Class C

Alphabets quarterly earnings miss and sharp post-report selloff dominate discussion, with traders concerned about weaker search and ad results alongside heavy AI infrastructure spending and pressure on cash flow. The strong Google Cloud growth offers a counterpoint, and some traders view the decline as an overreaction or buying opportunity.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNows quarterly report triggered a sharp selloff: revenue and full-year guidance were strong, but a small earnings miss and softer-than-expected forward growth outlook disappointed investors amid elevated expectations. Traders are divided between calling the drop an overreaction given continued growth and AI momentum, and viewing it as a valuation reset reflecting decelerating growth and pressure on software stocks.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracles investor-day outlook for rapid cloud and AI growth, a path to positive free cash flow, and lower future capital spending sparked a sharp rally by easing concerns about debt and infrastructure costs. Bulls welcomed the added financing clarity, while skeptics questioned whether the ambitious long-term projections and AI commitments can be delivered.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Feds rate hold, two hawkish dissents and Chair Warshs comments drove choppy QQQ trading, with traders debating whether inflation risks point to future hikes. Alphabets earnings and concerns about AI spending added pressure on tech, while Microsofts stronger results provided a counterpoint.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsofts quarterly results beat expectations, with accelerating Azure growth and capital spending below forecasts fueling an initial rally. Traders debated whether strong cloud momentum validates AI investment or whether weaker free cash flow and fading gains point to concerns about returns and elevated expectations.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS said its Phase 3 REGAL trial reached the prespecified 80th event, triggering database lock, unblinding and analysis ahead of topline results. The milestone was followed by a sharp selloff, prompting debate over profit-taking and risk ahead of a binary readout versus the bullish view that the trial has advanced but its outcome remains unknown.

Fortinet, Inc. provides cybersecurity solutions to a variety of businesses, such as enterprises, communication service providers, government organizations, and small to medium-sized businesses. Its product portfolio includes network security, secure access service edge, enterprise networking, security operations, application security, and operational technology. The company was founded by Ken Xie and Michael Xie in November 2000 and is headquartered in Sunnyvale, CA.

Fortinet Inc

Fortinet shares are under sharp pressure despite quarterly results beating estimates and higher full-year guidance; traders are debating whether the reaction reflects lofty expectations and margin concerns or an overreaction. The selloff is also weighing on cybersecurity peers, while some investors are treating the drop as a buying opportunity.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is rebounding alongside neocloud and AI-infrastructure stocks as traders focus on strong AI and cloud spending, SK Hynixs results, and optimism about demand for computing capacity. Bulls view the move as a recovery in the AI trade, with possible short-covering after a steep pullback; bears continue to flag financing needs, debt, and valuation risk.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Vikings Q3 update highlighted progress in VK2735 obesity trials and positive maintenance-study results, but investors are focused on the lack of new partnership or commercialization clarity. The community is divided between optimism about the pipeline and concern that ongoing cash burn, recent financing and possible future dilution could weigh on shares.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLNPR NewswireNEW YORK, Oct. 22, 2026 NEW YORK, Oct. 22, 2026 /PRNewswire/ -- Pomerantz LLP is...

Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.

Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich. Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.PR NewswireNORTHFIELD, Ill., Oct. 15, 2026State-of-the-art facility planned to reinforce...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLNPR NewswireNEW YORK, Oct. 15, 2026NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP is...

MDLN Stock Alert: Medline Product Quality Issues and Subsequent 13% Stock Drop Trigger Securities Fraud Investigation for Investors

MDLN Stock Alert: Medline Product Quality Issues and Subsequent 13% Stock Drop Trigger Securities Fraud Investigation for Investors MDLN Stock Alert: Medline Product Quality Issues and Subsequent 13% Stock Drop Trigger Securities Fraud Investigation for InvestorsPR NewswireNEW YORK, Oct. 13...

Medline launches enhanced TrackPoint to simplify inventory management for post-acute care

Medline launches enhanced TrackPoint to simplify inventory management for post-acute care Medline launches enhanced TrackPoint to simplify inventory management for post-acute carePR NewswireNORTHFIELD, Ill., Oct. 12, 2026Combines real-time inventory tracking with PointClickCare integration to...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLNPR NewswireNEW YORK, Oct. 8, 2026NEW YORK, Oct. 8, 2026 /PRNewswire/ --Pomerantz LLP is...

MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firms Securities Investigation Following 12.8% Share Drop

The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Medline Inc. (Medline or the Company) (NASDAQ: MDLN) investors concerning the Companys and/or members of its senior managements possible violation of the federal securities laws or other unlawful business...

MDLN Stock Notice: Medline Stock Plummeted 13% after Product Quality Issues Disclosed - Securities Fraud Investigation Underway

MDLN Stock Notice: Medline Stock Plummeted 13% after Product Quality Issues Disclosed - Securities Fraud Investigation Underway MDLN Stock Notice: Medline Stock Plummeted 13% after Product Quality Issues Disclosed - Securities Fraud Investigation UnderwayPR NewswireNEW YORK, Oct. 6, 2026BFA Law is...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLNPR NewswireNEW YORK, Oct. 1, 2026NEW YORK, Oct. 1, 2026 /PRNewswire/ --Pomerantz LLP is...

Medline Legal Alert: Medline (MDLN) Investors who Lost Money are Notified of the Ongoing Securities Fraud Investigation

Medline Legal Alert: Medline (MDLN) Investors who Lost Money are Notified of the Ongoing Securities Fraud Investigation Medline Legal Alert: Medline (MDLN) Investors who Lost Money are Notified of the Ongoing Securities Fraud InvestigationPR NewswireNEW YORK, Sept. 29, 2026 BFA Law is investigating...

Medline, Inc. engages in the provision of medical-surgical products and supply chain solutions. It operates through the Medline Brand and Supply Chain Solutions segments. The Medline Brand segment is involved in the procurement and manufacture of products from surgical solutions, front line care, and laboratory and diagnostics categories. The Supply Chain Solutions segment focuses on procurement and distribution of a variety of third-party products from national brands and provides tailored logistics and supply chain optimization services to domestic and international consumers. The company was founded by Jim Mills and Jon Mills in 1966 and is headquartered in Northfield, IL.

Medline Inc - Ordinary Shares - Class A

Medline Stock Soars In Debut As Medical Supply Giant Seals 2025’s Biggest IPO

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>Shares opened well above the offer price, valuing the company at roughly $47 billion after an upsized offering.</li><li>Proceeds are largely being used to reduce debt, with private equity backers partially exiting through the sale.</li><li>The debut marks the largest U.S. IPO since 2021, signaling renewed appetite for large public listings.</li></ul><p>Medline (MDLN) shares surged nearly 30% on Wednesday in their first day of trading, marking a blockbuster debut for the medical-supplies company after it raised $6.26 billion in the largest initial public offering of 2025.</p><p>The stock opened at $35 a share, well above its IPO price of $29, giving Medline a market value of about $47 billion based on shares outstanding disclosed in regulatory filings.</p><h2 class="st-heading-2"><strong>New High For 2025 IPOs</strong></h2><p>Medline sold roughly 216 million shares in an&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/medical-supply-giant-medline-upsizes-ipo-and-sets-29-price-ahead-of-wednesday-nasdaq-debut/cLeJprcREpi">upsized offering</a> priced at $29 a share, after increasing the deal size from its earlier filing.</p><p>The IPO surpasses the previous largest listing of the year, a $5.26 billion Hong Kong offering by China’s Contemporary Amperex Technology, and marks the biggest U.S. IPO since Rivian Automotive’s $13.7 billion debut in 2021.</p><h2 class="st-heading-2"><strong>Backers And Use Of Proceeds</strong></h2><p>The company counts Blackstone, Carlyle Group and Hellman &amp; Friedman among its major shareholders.</p><p>Medline said most of the proceeds from newly issued shares will be used to reduce debt and strengthen its balance sheet, with the remainder allocated to general corporate purposes and offering-related expenses. Proceeds from shares sold by existing holders will go toward buying out equity interests from certain pre-IPO owners.</p><h2 class="st-heading-2"><strong>A Medical Supply Giant At Scale</strong></h2><p>Medline describes itself as the largest provider of medical-surgical products and supply-chain services by net sales. Its catalog includes roughly 335,000 products used across hospitals, surgery centers, physicians’ offices and post-acute care facilities.</p><p>About one-third of Medline’s branded products are manufactured in-house across 33 facilities, while the rest are sourced from more than 500 suppliers in around 40 countries. The company also distributes about 145,000 third-party products through its supply-chain services business.</p><h2 class="st-heading-2"><strong>Financial Performance</strong></h2><p>Medline posted $20.6 billion in net sales and $1 billion in profit for the first nine months of 2025. This came after the company reported $25.5 billion in revenue and $1.2 billion in net income in 2024. The company reported that sales have grown annually since its inception and is helped by recurring revenue from long-term customer contracts.</p><p>Prime Vendor agreements, which designate Medline as a primary supplier, generated $16 billion in net sales in 2024. The company said retention under those contracts has averaged more than 98% over the past five years.</p><h2 class="st-heading-2"><strong>IPO Momentum Builds</strong></h2><p>Medline’s strong debut comes as Wall Street attention increasingly turns to the next wave of mega listings. Markets have been buzzing for more than a week around expectations that&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/will-spacex-ticker-be-mars-spax-or-sex-polymarket-bets-reveal-odds/cLeO1qrREq9">SpaceX could go public</a> at a valuation of roughly $1.5 trillion, which would make it the largest IPO in history, potentially in mid-to-late 2026.&nbsp;</p><p>SpaceX CEO Elon Musk earlier this week indicated that media reports around the aerospace company’s IPO plans are accurate.</p><h2 class="st-heading-2"><strong>How Did Stocktwits Users React?</strong></h2><p>On Stocktwits, retail sentiment for Medline was ‘extremely bullish’ amid ‘extremely high’ message volume.</p><figure class="image"><img style="aspect-ratio:975/149;" src="https://news.stocktwits-cdn.com/mdln_ss_png_91dc8d27a6.webp" alt="mdln ss.png" width="975" height="149"><figcaption>MDLN sentiment and message volume as of December 17| Source: Stocktwits</figcaption></figure><p>One user said, “lezgo! Bought $10K @ $36.62. Let's see where this takes us.”&nbsp;</p><p><stembedurl>https://stocktwits.com/jvbiotek/message/639462113</stembedurl></p><p>Another user predicted that “this share will keep raising, medical equipments are essential business.”&nbsp;</p><p><stembedurl>https://stocktwits.com/x828282/message/639461407</stembedurl></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration, the Medline logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

The company's first day on the market underscored strong investor demand for scaled, profitable issuers as the U.S. IPO pipeline shows strength.

Medline Inc.

Yes, the bottom is in

No, more downside ahead

Too early to tell

Depends on the stock

Neocloud stocks like $NBIS, $CRWV, $IREN, and $APLD are rebounding after a brutal October. Have they bottomed?

Current Price	$32.37
Prev Close	$32.38
Open	$32.13
Dividend Yield	0.00%
50-Day Moving Average	$34.59
Beta	0.13
Avg. Volume	8.62M
PE Ratio	37.97

52-Week High	$50.88
52-Week Low	$29.00
Market Capitalization	$42.57B
EPS (Annual)	$1.43
Price to Book	2.45
Revenue Per Employee	$631,822.22

Feed

News

Sentiment

Earnings

Fundamentals

Info

MDLN Fundamentals